|
|
2. |
Shah DC, Takahashi A, Jaïs P, Hocini M, Peng JT, Clementy J,
Haïssaguerre M. Tracking dynamic conduction recovery across the
cavotricuspid isthmus. J Am Coll Cardiol 2000; 35:1478
–1484. |
3
|
Keim S, Curtis AB, Belardinelli L, Epstein ML, Staples ED,
Lerman BB. Adenosine-induced atrioventricular block: a rapid and
reliable method to assess surgical and radiofrequency catheter ablation
of accessory atrioventricular pathways. J Am Coll Cardiol 1992;
19:1005-12.
|
4
|
Alvarez M, Tercedor L, Lozano JM, González-Molina M, Fernández
JC, Figueras M, Azpitarte J. Utility of adenosine 5’-triphosphate in
predicting early recurrence after successful ablation of manifest
accessory pathways. Heart Rhythm 2004;
1:648-55.
|
5
|
Arentz T, Macle L, Kalusche D, Hocini M, Jais P, Shah D,
Haissaguerre M. “Dormant” pulmonary vein conduction revealed by
adenosine after ostial radiofrequency catheter ablation. J Cardiovasc
Electrophysiol 2004;
15:1041–1047.
|
6
|
Yamada T, Murakami Y, Plumb VJ, Kay GN. Adenosine can also
improve the conduction between the superior vena cava and right atrium
after isolation. J Cardiovasc Electrophysiol 2006;
17:1246–1249.
|
7
|
Datino T, Macle L, Qi XY, Maguy A, Comtois P, Chartier D,
Guerra PG, Arenal A, Fernández-Avilés F, Nattel S. Mechanisms by which
adenosine restores conduction in dormant canine pulmonary veins.
Circulation 2010;
121:963-72.
|
8 |
Vijayaraman P, Dandamudi G, Naperkowski A, Oren J, Storm R,
Ellenbogen K. Adenosine facilitates dormant conduction across
cavotricuspid isthmus following catheter ablation. Heart Rhythm
2012;9:1785-1788. |
9 |
Morales G, Darrat YH, Lellouche N, Kim SM, Butt M, Bidwell K,
Lippert W, Ogunbayo G, Hamon D, Di Biase L, Natale A, Parrott K, Elayi
CS. Use of adenosine to shorten the post ablation waiting period for
cavotricuspid isthmus-dependent atrial flutter. J Cardiovasc
Electrophysiol 2017; 28:876-881. |
10 |
Bru P, Duplantier C, Bourrat M, Valy Y, Lorillard R. Resumption of
right atrial isthmus conduction following atrial flutter radiofrequency
ablation. Pacing Clin Electrophysiol 2000; 23:1908-10. |
11 |
DiMarco JP, Sellers TD, Berne RM, West GA, Belardinelli L.
Adenosine: electrophysiologic effects and therapeutic use for
terminating paroxysmal supraventricular tachycardia. Circulation 1983;
68:1254-63. |
12 |
Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ,
Estes NAM 3rd, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay
BD, Olshansky B, Russo AM, Shen WK, Tracy CM, Al-Khatib SM. ACC/AHA/HRS
Guideline for the Management of Adult Patients With Supraventricular
Tachycardia A Report of the American College of Cardiology/American
Heart Association Task Force on Clinical Practice Guidelines and the
Heart Rhythm Society. J Am Coll Cardiol 2016;
67:e27-e115. |
13 |
Macle L, Khairy P, Weerasooriya R, Novak P, Verma A, Willems S,
Arentz T, Deisenhofer I, Veenhuyzen G, Scavée C, Jaïs P, Puererfellner
H, Levesque S, Andrade JG, Rivard L, Guerra PG, Dubuc M, Thibault B,
Talajic M, Roy D, Nattel S; ADVICE trial investigators. Adenosine-guided
pulmonary vein isolation for the treatment of paroxysmal atrial
fibrillation: an international, multicentre, randomised superiority
trial. Lancet 2015; 386:672-9. |
14 |
Kumagai K, Naito S, Nakamura K, Hayashi T, Fukazawa R, Sato C,
Takemura N, Miki Y, Fuke E, Tanaka Y, Hori Y, Goto K, Iwamoto J, Aonuma
K, Oshima S, Taniguchi K. ATP-induced dormant pulmonary veins
originating from the carina region after circumferential pulmonary vein
isolation of atrial fibrillation. Journal of Cardiovascular
Electrophysiology 2010; 21:494–500. |
15 |
Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJ.
Adenosine versus intravenous calcium channel antagonists for
supraventricular tachycardia. Cochrane Database Syst Rev. 2017 Oct
12;10:CD005154. |